Differences in willingness to pay for artemisinin-based combinations or monotherapy: experiences from the United Republic of Tanzania

• Asıl Yazarlar: Virginia Wiseman (Yazar), Obinna Onwujekwe (Yazar), Fred Matovu (Yazar), Theonest K. Mutabingwa (Yazar), Christopher J.M. Whitty (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: The World Health Organization, 2005-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

OBJECTIVE: The cost of combination treatment is thought to be one of the greatest barriers to their deployment, but this has not been tested directly. Estimates of willingness to pay were compared across four drug combinations used to treat Tanzanian children with uncomplicated malaria. The reasons...